Transcatheter aortic valve implantation: 10-year anniversary. Part II: Clinical implications
Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.
|Keywords||Aortic stenosis, TAVI, TAVR|
|Persistent URL||dx.doi.org/10.1093/eurheartj/ehs223, hdl.handle.net/1765/65750|
|Journal||European Heart Journal|
Généreux, P, Head, S.J, Wood, D.A, Kodali, S, Williams, M.R, Paradis, J, … Leon, M.B. (2012). Transcatheter aortic valve implantation: 10-year anniversary. Part II: Clinical implications. European Heart Journal (Vol. 33, pp. 2399–2402). doi:10.1093/eurheartj/ehs223